User:Allen Bain

The account of this former contributor was not re-activated after the server upgrade of March 2022.

Allen Bain, PhD – Chief Science Officer, Stirling Products Ltd., Sydney Australia – for over 20 years has held leadership roles in both the business and the science of drug discovery and commercialisation. He is currently a non executive director of Zodiac Capital Limited in Sydney. Dr Bain was a co-founder of Cardiome Pharma, Vancouver Canada (Nasdaq:CRME) and has been a co-founder, officer, or director of several other public companies in Canada, USA, and Australia. Dr Bain's PhD was granted in 1985 for work in synaptic neuropharmacology.